Five more years! Not everything changes

F. Khuri

DOI: https://doi.org/10.1002/cncr.30552

IF: 6.9209

Cancer

Abstract:The year 2016 was certainly extraordinary. Amidst all the turmoil of US and international elections, global wars, and heart-rending refugee crises, some constancy is necessary. Donald Trump is now the president of the United States, and Fidel Castro is gone, but some things are not yet ready for change! As many of you have known for some time, I left Emory University’s Winship Cancer Institute in the summer of 2015 and have served as the president of the American University of Beirut for the last year and a half. However, although I felt that my work at Emory was largely finished, as I mentioned in my last editorial, there is much work still to do to realize our shared goals for Cancer. This is the major reason that I have decided to continue as editor-in-chief of the journal for 5 more years through the summer of 2021. By virtually all measures, we have witnessed substantial progress for our field’s flagship journal during the last 5 years. Some of this progress is easy to quantify. Our ranking in the field of oncology, as measured by the Journal Citation Reports, has now improved to 26th out of more than 210 journals, our impact factor has risen from approximately 4.7 to 5.7 during the last 5 years despite increased competition (Fig. 1), and our full-text downloads have increased dramatically over the last few years (Fig. 2). We have also adopted a more effective social media presence, which has yielded quick and impressive results, with online mentions of our articles more than doubling in the last 3 years alone (Fig. 3). Our times to first editorial decision and to online publication have declined dramatically, and this reflects that our journal is one of the most efficient, user-friendly journals in our field (Figs. 4 and 5). My first editorial of 11 so far was entitled “Why Cancer Matters.” I would argue that with our broad mission, engaged readership, and ever-improving content, Cancer matters now more than ever before as a journal even as cancer matters more than ever as a global public health menace. As we showed last year in our special issue on lung cancer in China, the scourge of tobacco-related diseases is likely to increase in the world’s most populous nations, with analogous increases highly likely in many other parts of the globe. With increased environmental carcinogens and with much of the world adopting a rapid, high-calorie, far-from-healthy diet, it is unlikely that, despite the ambitious agendas of presidents and cancer center directors, the moon shots will cure all that ails our ever-increasing population of cancer survivors.